JOCELYN FOSTER: Open Payments
NPI 1255968798 · MAPLE SHADE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 47 payments from 12 companies in 2025. Trend: 2023 $404 · 2024 $875 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $271 |
| PFIZER INC. | 5 | $92 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| ABBVIE INC. | 4 | $79 |
| Exact Sciences Corporation | 3 | $77 |
| Lilly USA, LLC | 4 | $71 |
| Janssen Pharmaceuticals, Inc | 4 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| IBSA Pharma Inc. | 1 | $18 |
Products named: Rybelsus, Cologuard Collection Kit, PREVNAR 20, MOUNJARO, Wegovy, SPRAVATO, VRAYLAR, Ozempic.
Industry payments across NJ — which companies pay providers there.
